Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer

Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer

<p>Abstract</p> <p>Background</p> <p>The VEGF family of ligands and receptors are intimately involved in tumor angiogenesis, lymphangiogenesis and metastasis. The evaluation of VEGF ligand/receptor ratios may provide a more profound understanding of the involvement of t...

Full description

Bibliographic Details
Main Authors:	Terracciano Luigi, Baumhoer Daniel, Zlobec Inti, Eppenberger Manuela, Lugli Alessandro
Format:	Article
Language:	English
Published:	BMC 2010-03-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/10/93

Similar Items

Immuno-Contexture and Immune Checkpoint Molecule Expression in Mismatch Repair Proficient Colorectal Carcinoma
by: Mauro Giacomelli, et al.
Published: (2023-06-01)

Characterization of <it>CDKN2A</it>(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing
by: Bihl Michel P, et al.
Published: (2012-08-01)

Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era?
by: Laura Matteucci, et al.
Published: (2023-10-01)

Spatial transcriptome unveils a discontinuous inflammatory pattern in proficient mismatch repair colorectal adenocarcinoma
by: Rongxin Zhang, et al.
Published: (2023-07-01)

Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients
by: Shou-Sheng Liu, et al.
Published: (2018-07-01)

IGSF6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancer
by: Yu-ming Rong, et al.
Published: (2023-11-01)

Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients
by: Min Jin, et al.
Published: (2022-10-01)

Risk for Hereditary Neoplastic Syndromes in Women with Mismatch Repair-Proficient Endometrial Cancer
by: Jennifer Thalita Targino dos Santos, et al.
Published: (2023-10-01)

Serrated adenocarcinoma of sigmoid colon with mismatch repair protein‐proficient phenotype: Histopathological recognition of a new subtype of colorectal adenocarcinoma
by: Diksha Karki, et al.
Published: (2024-03-01)

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
by: Mark Yarchoan, et al.
Published: (2020-02-01)

Orthotopic liver metastasis mouse models of mismatch repair-proficient colorectal cancer recapitulate clinical inefficacy of immune checkpoint blockade
by: Ho, William Wee Teck.
Published: (2021)

Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer
by: Yinjun He, et al.
Published: (2023-01-01)

Immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study
by: Marine Jary, et al.
Published: (2022-06-01)

DNA mismatch repair genes and colorectal cancer.
by: Wheeler, J, et al.
Published: (2000)

Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer
by: Dae Won Kim, et al.
Published: (2024-01-01)

Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers
by: Jinming Li, et al.
Published: (2023-08-01)

Mismatch Repair Testing in Colorectal Cancer - Is Less More?
by: Hutchins, G, et al.
Published: (2012)

Immune Checkpoint Inhibitors in Mismatch Repair Proficient/Microsatellite Stable Metastatic Colorectal Cancer Patients: Insights from the AtezoTRIBE and MAYA Trials
by: Marco Maria Germani, et al.
Published: (2021-12-01)

BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors
by: Li Zhang, et al.
Published: (2023-04-01)

The microbial genotoxin colibactin exacerbates mismatch repair mutations in colorectal tumors
by: Michael W. Dougherty, et al.
Published: (2023-09-01)

Role of <it>APC </it>and DNA mismatch repair genes in the development of colorectal cancers
by: Roy Deodutta, et al.
Published: (2003-12-01)

Expression of programmed cell death ligand-1 and mismatch repair status in endometrial carcinomas
by: Madhubala Rajendran, et al.
Published: (2023-01-01)

A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOX
by: Zhu J, et al.
Published: (2023-02-01)

Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas.
by: Bicknell, D, et al.
Published: (1996)

Deficient mismatch repair/microsatellite unstable colorectal cancer: therapeutic advances and questions
by: Baptiste Cervantes, et al.
Published: (2024-01-01)

Prognostic and Predictive Values of Mismatch Repair Deficiency in Non-Metastatic Colorectal Cancer
by: Zhaohui Jin, et al.
Published: (2021-01-01)

Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer
by: Yurong Song, et al.
Published: (2023-09-01)

Immunohistochemical phenotype of colorectal carcinoma in patients with KRAS mutation and mismatch repair status
by: Desislava Tashkova, et al.
Published: (2023-06-01)

Mismatch repair system in colorectal cancer. Frequency, cancer phenotype, and follow-up
by: J. Rios-Valencia, et al.
Published: (2022-10-01)

Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 studyResearch in context
by: Marwan Fakih, et al.
Published: (2023-04-01)

Case report: mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance
by: Kuo-Hsing Chen, et al.
Published: (2016-03-01)

Meta-analysis of mismatch repair polymorphisms within the cogent consortium for colorectal cancer susceptibility
by: Picelli, S, et al.
Published: (2013)

Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours.
by: Homfray, T, et al.
Published: (1998)

A prospective study confirms mismatch repair status predicts outcome in colorectal cancer
by: Chandler, I, et al.
Published: (2006)

DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma
by: Cheah, Phaik Leng, et al.
Published: (2018)

Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer
by: Ivan Vlahović, et al.
Published: (2023-05-01)

Correlation between mismatch repair statuses and the prognosis of stage I–IV colorectal cancer
by: Guojun Tong, et al.
Published: (2024-01-01)

Evaluation of mismatch-repair and microsatellite-instability status in a Chinese colorectal cancer Cohort
by: Peng Zhang, et al.
Published: (2024-02-01)

Routine Immunohistochemical Analysis of Mismatch Repair Proteins in Colorectal Cancer—A Prospective Analysis
by: Joana Lemos Garcia, et al.
Published: (2022-07-01)

DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma
by: Phaik-Leng Cheah, et al.
Published: (2018-09-01)